10x Genomics, Inc. (LON:0A88)
12.58
+0.04 (0.28%)
At close: Aug 7, 2025
10x Genomics Revenue
10x Genomics had revenue of $172.91M USD in the quarter ending June 30, 2025, with 12.94% growth. This brings the company's revenue in the last twelve months to $644.47M, up 2.02% year-over-year. In the year 2024, 10x Genomics had annual revenue of $610.79M, down -1.28%.
Revenue (ttm)
$644.47M
Revenue Growth
+2.02%
P/S Ratio
2.50
Revenue / Employee
$493.47K
Employees
1,306
Market Cap
1.17B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 610.79M | -7.94M | -1.28% |
Dec 31, 2023 | 618.73M | 102.32M | 19.81% |
Dec 31, 2022 | 516.41M | 25.92M | 5.28% |
Dec 31, 2021 | 490.49M | 191.65M | 64.13% |
Dec 31, 2020 | 298.85M | 52.95M | 21.53% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
British American Tobacco p.l.c. | 25.60B |
Rolls-Royce Holdings | 19.54B |
Rio Tinto Group | 39.22B |
RELX PLC | 9.53B |